Durect Corp (DRRX)
0.93
-0.01
(-1.46%)
USD |
NASDAQ |
May 17, 16:00
0.9395
+0.01
(+1.02%)
After-Hours: 20:00
Durect Cash from Financing (Quarterly): -1.495M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.495M |
December 31, 2023 | -1.226M |
September 30, 2023 | 11.76M |
June 30, 2023 | -0.034M |
March 31, 2023 | 10.00M |
December 31, 2022 | 0.024M |
September 30, 2022 | 0.025M |
June 30, 2022 | 0.026M |
March 31, 2022 | 0.008M |
December 31, 2021 | 0.151M |
September 30, 2021 | -0.117M |
June 30, 2021 | -0.55M |
March 31, 2021 | 51.05M |
December 31, 2020 | 0.45M |
September 30, 2020 | 7.103M |
June 30, 2020 | 7.347M |
March 31, 2020 | 0.76M |
December 31, 2019 | 3.86M |
September 30, 2019 | 0.242M |
June 30, 2019 | 15.34M |
March 31, 2019 | 0.057M |
December 31, 2018 | -0.859M |
September 30, 2018 | -0.004M |
June 30, 2018 | 4.242M |
March 31, 2018 | 14.10M |
Date | Value |
---|---|
December 31, 2017 | 2.534M |
September 30, 2017 | 5.059M |
June 30, 2017 | 4.274M |
March 31, 2017 | 0.757M |
December 31, 2016 | 3.58M |
September 30, 2016 | 0.938M |
June 30, 2016 | 17.24M |
March 31, 2016 | 1.32M |
December 31, 2015 | 2.833M |
September 30, 2015 | -0.107M |
June 30, 2015 | 12.24M |
March 31, 2015 | 0.238M |
December 31, 2014 | 0.078M |
September 30, 2014 | 4.729M |
June 30, 2014 | 19.89M |
March 31, 2014 | 0.09M |
December 31, 2013 | 10.84M |
September 30, 2013 | 0.062M |
June 30, 2013 | 0.083M |
March 31, 2013 | 0.00 |
December 31, 2012 | 11.73M |
September 30, 2012 | 0.062M |
June 30, 2012 | 0.048M |
March 31, 2012 | -0.002M |
December 31, 2011 | 0.131M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.495M
Minimum
Mar 2024
51.05M
Maximum
Mar 2021
5.236M
Average
0.1965M
Median
Cash from Financing (Quarterly) Benchmarks
Harrow Inc | -0.809M |
Stereotaxis Inc | 0.03M |
Cara Therapeutics Inc | -0.685M |
Voyager Therapeutics Inc | 112.86M |
Journey Medical Corp | 1.637M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -6.766M |
Cash from Investing (Quarterly) | -0.887M |
Free Cash Flow | -31.92M |
Free Cash Flow Per Share (Quarterly) | -0.2208 |
Free Cash Flow to Equity (Quarterly) | -4.715M |
Free Cash Flow Yield | -122.1% |